Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors ; volume:55 ; number:8 ; day:5 ; month:6 ; year:2023 ; pages:1943-1949 ; date:8.2023
International urology and nephrology ; 55, Heft 8 (5.6.2023), 1943-1949, 8.2023
- Urheber
-
Oppolzer, Immanuel Augustin
Riester, Josef
Büttner, Roland
Burger, Maximilian
Schnabel, Marco Julius
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11255-023-03635-9
- URN
-
urn:nbn:de:101:1-2023101208575554610904
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oppolzer, Immanuel Augustin
- Riester, Josef
- Büttner, Roland
- Burger, Maximilian
- Schnabel, Marco Julius
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
A signature of immune-related genes correlating with clinical prognosis and immune microenvironment in sepsis
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
A signature of immune-related genes correlating with clinical prognosis and immune microenvironment in sepsis
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
A signature of immune-related genes correlating with clinical prognosis and immune microenvironment in sepsis
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors